• SARS-CoV-2 Release: RNAi Maps Rab11a Transport

  2026-08-17

  Kerr et al. used an arrayed, druggable-genome RNA interference screen with virus-production measurements at two timepoints to identify host factors acting across the SARS-CoV-2 replication and reinfection cycle. The study highlights Rab11a-mediated vesicular cargo delivery as a conserved proviral pathway and shows that pharmacological CDK9 inhibition can prevent viral release, providing a framework for host-targeted antiviral research.

• Crizotinib hydrochloride in Gastric Cancer Models

  2026-08-16

  Learn how to use Crizotinib hydrochloride as a pharmacologic probe in matched gastric tumor organoid and stromal assembloid workflows. The approach separates tumor-cell target engagement from microenvironment-driven changes in viability, signaling, and drug sensitivity.

• Omeprazole A2845: H+,K+-ATPase Workflow

  2026-08-15

  Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research, antiulcer activity study design, and related in vitro or ex vivo workflows. Its water and ethanol insolubility requires DMSO-based stock preparation and careful vehicle, precipitation, and stability controls; it is not intended for diagnostic, clinical, or medical use.

• Live-Dead Cell Staining Kit: Calcein-AM/PI Guide

  2026-08-14

  The Live-Dead Cell Staining Kit K2081 uses Calcein-AM and Propidium Iodide to distinguish esterase-active, membrane-intact cells from membrane-compromised cells. This Calcein-AM Propidium Iodide staining workflow supports cell viability assay development in microscopy, flow cytometry, cytotoxicity, and apoptosis research.

• Fenofibrate, PPARα–YAP Signaling in Aging Livers

  2026-08-14

  The reference study demonstrates that Fenofibrate induces comparable liver enlargement and PPARα–YAP pathway activation in adult and aging mice. By combining multiple aging models with morphological and protein-level analyses, it shows that this hepatic response is largely independent of age and provides a framework for evaluating PPARα agonists in gerontological and metabolic research.

• ML-Designed LNPs for Microglia mRNA Delivery

  2026-08-13

  The 2025 Drug Delivery study combined a 216-formulation lipid nanoparticle library with supervised machine learning to predict mRNA transfection and microglial phenotype changes. Its best-performing model identified HA-LNP2, which delivered IL10 mRNA and reduced inflammatory features in both murine and human iPSC-derived microglia, providing a framework for designing carriers that actively contribute to immunomodulation.

• Calnexin-Dependent CFTR Variant Rescue

  2026-08-13

  Tedman et al. used deep mutational scanning to examine how the ER chaperone calnexin shapes expression and corrector responsiveness across 232 clinical CFTR variants. The study shows that calnexin dependence is strongly variant- and domain-specific, providing a mechanistic framework for interpreting heterogeneous responses in cystic fibrosis transmembrane conductance regulator modulation.

• Doxycycline for AAA: From MMP Biology to Delivery

  2026-08-12

  Doxycycline is a tetracycline antibiotic with research value beyond antimicrobial assays, including metalloproteinase inhibition in abdominal aortic aneurysm models. This guide translates targeted nanoparticle findings into practical decisions about controls, formulation, endpoints, and translational interpretation.

• FAISL lncRNA Stabilizes FAK in TNBC Metastasis

  2026-08-12

  The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by preventing Calpain 2-mediated proteolysis in triple-negative breast cancer. Its results connect RNA–protein interaction, focal-adhesion signaling, and metastatic behavior, while also illustrating how reduction-responsive siRNA delivery may be used to test FAISL as a therapeutic target.

• Syringin Targets EGFR/PI3K/Akt in Renal Cell Carcinoma

  2026-08-11

  A 2024 study identifies syringin as a potential renal cell carcinoma treatment component that suppresses malignant phenotypes and increases sunitinib sensitivity. By integrating network pharmacology, molecular docking, bioinformatics, cellular assays, and western blotting, the authors associate these effects with inhibition of the EGFR/PI3K/Akt pathway.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-08-11

  The Tricine-SDS-PAGE Gel Preparation Kit is intended for higher-resolution protein electrophoresis and peptide separation in the low-kilodalton range, where conventional Tris-glycine SDS-PAGE may provide limited separation. It is suitable for denaturing or non-denaturing research workflows when configured appropriately, but it is not intended for diagnostic or medical use.

• DiscoveryProbe Protease Inhibitor Library Guide

  2026-08-10

  The DiscoveryProbe Protease Inhibitor Library turns 825 pre-dissolved compounds into an automation-ready platform for protease inhibition, apoptosis assay development, and phenotype-first screening. This guide connects biochemical kinetics with high-content imaging while using the DdmDE defense study to sharpen target-engagement and time-resolved assay design.

• (S)-(+)-Ibuprofen COX Inhibitor Workflows

  2026-08-09

  Build cleaner inflammation assays with an enantiopure COX inhibitor, from solvent-compatible stock preparation to orthogonal prostaglandin and viability readouts. The same workflow can be extended cautiously into environmental toxicology, where ibuprofen concentration, persistence, and stereochemistry affect interpretation.

• Aging, Mitochondrial ROS, and Macrophage Phagocytosis

  2026-08-08

  The reference study identifies a mechanistic link between aging, mitochondrial reactive oxygen species, collagen overproduction, and defective macrophage phagocytosis. Its experiments suggest that collagen-mediated disruption of F-actin dynamics is a targetable downstream process, while MitoTEMPO partially restores bacterial uptake in aged macrophages.

• Fe3O4@ZIF-8 for Jaw Osteomyelitis: Dual Action

  2026-08-07

  The reference study presents Fe3O4@ZIF-8 core–shell nanoparticles as a platform that combines pH-responsive antibacterial activity with magnetic-field-assisted bone regeneration. Its central contribution is to address the coupled problems of persistent infection and bone loss in jaw osteomyelitis through Zn2+ release, bacterial stress sensitization, and Fe3O4-mediated osteogenic support.

8499 records 3/567 page Previous Next 12345 下5页 Last page